Biodefense Treatment Market

Demand for Biodefense Treatment to See an Exponential Rise in the Wake of Potential Bioterrorist Attacks

The COVID-19 pandemic has caused the monumental loss of lives, and damage to the economy, social stability, and global security. In many ways, it has raised questions about the biological warfare, reigniting conversations around biodefense. Despite the United Nations convention against biological warfare, the possibility of bioterrorist attacks seems to be real more than ever. To battle the biological threats, and rogue pathogenic attacks, countries are expected to expand their budgets for research and development of biodefense treatments, creating revenue generation opportunities in biodefense treatment market. In the light of these current affairs, global biodefense treatment market is likely to witness an exponential spike in the next five years. Fairfield Market Research throws light on how the growth of biodefense treatment market will unfold over the period of next few years.

Growing Geo-political Conflicts to Drive Global Biodefense Market Growth

The ascending threat of bioterrorism, coupled with rising geo-political tensions across the world have given every reason to nations to strengthen their arsenal. Governments from all corners are ramping up defence budgets with dedicated allocations to biological and chemical defence mechanisms. A multitude of geo-political escalations around the world and the recent pandemic have alerted defense strategists to rethink solutions. From the Middle East to South China Sea, many countries are locking horns to gain an upper hand geo-strategically.

Increase in mass awareness in relation to serious implications of biothreats have resulted in soaring demand for defensive systems and products. The growing emphasis on public health services towards development of diagnostics and procedures to detect biothreat agents is also driving biodefense treatment market. Technological advent in the discovery of pathogens in the fields of nanotechnology, forensics and biodefense-related drug development has helped market growth in recent times. As COVID-19 pandemic remains far from over, the already growing biodefense treatment market has set the tone for an upward momentum in R&D activities.

Vaccines to be the Key Line of Defense against Biothreats

Vaccines represented the leading product segment in terms of revenue as of 2019. There is significant interest from large biopharmaceutical companies in R&D activities. Heavy government expenditures in the development of vaccines are expected to continue. The US government is even working on the development and manufacturing of products to counter any bioterror attacks under Strategic National Stockpile (SNS). Sales of detection devices are expected to show moderate growth till 2025. There has been a notably growing adoption of rapid detection systems, which will trigger further growth in the segment. Detection devices have been the key component of US $100 billion federal effort to increase the nation’s bio-defence post 9/11.

The US Retains its Top Position with Considerable Federal Expenditure

Biodefense strategies from government departments of the United States, viz., HHS, BARDA, NIAID, and ASPR have been contributing toward the continued lead of the US in global biodefense treatment market. Meanwhile, Europe is increasingly being looked at as the fastest-growing region till 2025 as the top European countries have scaled up their R&D expenditure amid the course of COVID-19 pandemic. On the other hand, emerging markets from Asia Pacific region are fast catching up with their global competitors with a measurable surge in R&D expenditure for development, and manufacturing of COVID-19 vaccines, and other antitoxins for the different biological threats. Fairfield Market Research indicates that mature markets like Australia, and Japan will continue to benefit from the well-laid down quality, and safety norms for development and production facilities.

Leading Companies to Adopt Inorganic Route to Strengthen Market Share

The highly competitive market space has pushed leading players towards advanced technology adoption and strategic co-operations. In 2017, PharmAthene, and Altimmune merged to set up larger immunotherapeutic entity targeting infectious diseases. Some of the key companies competing in biodefense treatment market, include SIGA Technologies, Inc., Bavarian Nordic, Altimune, Inc. (PharmAthene, Inc.), Emergent BioSolutions Inc., Cleveland Biolabs, Xoma Corporation, Dynavax Technologies Corporation, Elusys Therapeutics, Inc., B.Ichor Medical Systems, Dynport Vaccine Company LLC, Achaogen, Inc., Nanotherapeutics, Inc., and Alnylam Pharmaceuticals, Inc.

The biodefense treatment market is segmented as below:

By Vaccine Type

• Anthrax
• Smallpox
• Botulism
• Others

By Biothreat Detection Device

• Samplers
• Detectors/Triggering Devices
• Identifiers
• Assays
• Others

By End User

• Hospitals and Clinics
• Ambulatory Care Centres
• Others

By Region

• North America
  • U.S.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Russia
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Latin America
  • Brazil
  • Mexico
• MEA
  • Saudi Arabia
  • UAE
  • South Africa

Key Elements Included In The Study: Global Biodefense Treatment Market

• Biodefense Treatment Market by Product/Technology/Grade, Application/End-user, and Region
• Executive Summary (Opportunity Analysis and Key Trends)
• Historical Market Size and Estimates, Value, 2018 - 2021
• Market Value at Regional and Country Level, 2022 - 2029
• Market Dynamics and Economic Overview
• Market Size in Value, Growth Rates, and Forecast Figures, 2022 - 2029
• Competitive Intelligence with Financials, Key Developments, and Portfolio of Leading Companies 
• Regional and Product/Grade/Application/End-user Price Trends Analysis
• Value Chain and Five Force’s Analysis
• Regional/Sub-region/Country Market Size and Trend Analysis
• Company Market Share Analysis and Key Player Profiles

Post Sale Support, Research Updates & Offerings

We value the trust shown by our customers in Fairfield Market Research. We support our clients through our post sale support, research updates and offerings.

• The report will be prepared in a PPT format and will be delivered in a PDF format.

• Additionally, Market Estimation and Forecast numbers will be shared in Excel Workbook.

• If a report being sold was published over a year ago, we will offer a complimentary copy of the updated research report along with Market Estimation and Forecast numbers within 2-3 weeks’ time of the sale.

• If we update this research study within the next 2 quarters, post purchase of the report, we will offer a Complimentary copy of the updated Market Estimation and Forecast numbers in Excel Workbook.

• If there is a geopolitical conflict, pandemic, recession, and the like which can impact global economic scenario and business activity, which might entirely alter the market dynamics or future projections in the industry, we will create a Research Update upon your request at a nominal charge.

Disclaimer:

• The segmentation/company profiles/countries depicted above may vary in the actual report.